We need access to data on all clinical trials, not just some

BMJ (Online)

Volumn 345, Issue 7885, 2012, Pages

  Wieseler, Beate ^a   McGauran, Natalie ^a   Kaiser, Thomas ^a  

^a INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

ACCESS TO INFORMATION; CLINICAL TRIAL (TOPIC); CONFIDENTIALITY; DATA BASE; DRUG APPROVAL; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; INFORMATION PROCESSING; INTERNET; LETTER; PATIENT INFORMATION; POLICY; PRIORITY JOURNAL; SYSTEMATIC ERROR; SYSTEMATIC REVIEW (TOPIC); WORKSHOP;

CLINICAL TRIALS AS TOPIC; INFORMATION DISSEMINATION;

EID: 84870566293     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e8001     Document Type: Letter

References (6)

1. Godlee F. Clinical trial data for all drugs in current use. BMJ 2012;345:e7304. (29 October.)
2. European Medicines Agency. European Medicines Agency widens public access to documents. 2010. www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/ news/2010/11/news-detail-001158.jsp&mid=WC0b01ac058004d5c1&murl=menus/ news- and-events/news-and-events.jsp.
3. European Medicines Agency. Workshop on clinical-trial data and transparency.22 November 2012. www.ema.europa.eu/ema/index.jsp?curl=pages/news- and-events/events/2012/07/event-detail-000656.jsp&mid=WC0b01ac058004d5c3.
4. Wieseler B, McGauran N, Kerekes MF, Kaiser T. Access to regulatory data from the European Medicines Agency: the times they are a-changing. Syst Rev 2012;1:50.
5. Eyding D, Lelgemann M, Grouven U, Harter M, Kromp M, Kaiser T, et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ 2010;341:c4737.
6. Doshi P, Jefferson T, Del Mar C. The imperative to share clinical study reports: recommendations from the Tamiflu experience. PloS Med 2012;9:e1001201.